Baseline hemodynamic predictors of treatment response in pulmonary arterial hypertension

C. Gerges, M. Gerges, Y. Zhou, L. Zhang, M. Lang, I. Lang (Vienna, Austria; Research Triangle Park, United States Of America)

Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Session: Pulmonary circulation: clinical pulmonary hypertension I
Session type: Thematic Poster Session
Number: 2621
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Gerges, M. Gerges, Y. Zhou, L. Zhang, M. Lang, I. Lang (Vienna, Austria; Research Triangle Park, United States Of America). Baseline hemodynamic predictors of treatment response in pulmonary arterial hypertension. Eur Respir J 2013; 42: Suppl. 57, 2621

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical and haemodynamic predictors of abnormal pulmonary vascular response at exercise
Source: International Congress 2015 – Pulmonary hypertension: new pathophysiological insights
Year: 2015


Gender differences in right-ventricular arterial coupling in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Impact of borderline pulmonary arterial pressure on survival
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016

Hemodynamic correlates of right ventricular afterload and pulmonary artery pulsatility under treatment with prostacyclin: Retrospective analysis of changes from baseline in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013

Age is independently associated with pulmonary arterial compliance in health and in patients with pulmonary vascular disease
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016

Sildenafil improves heart rate variability, pulmonary hemodynamics and functional status in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014

Cardiopulmonary comorbidities are associated with hemodynamics in pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015


Unique characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease compared to the rest of pulmonary arterial hypertension subgroups
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014


Acute haemodynamic effects of adaptive servoventilation therapy in patients with pulmonary arterial hypertension and patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015

Hemodynamic and clinical relevance of “borderline pulmonary hypertension“
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

An open label study of ambrisentan in patients with exercise induced pulmonary arterial hypertension (EiPAH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013


Afterload reduction governs improvement in RV systolic function and ventriculo-arterial adaptation in patients with pulmonary arterial hypertension (PAH) undergoing rapid dose escalation of treprostinil
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014

Specific pulmonary arterial hypertension therapy in COPD patients with severe pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


About cardiac output assessment in pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013

Pulmonary vascular reactivity in pulmonary hypertension due to left heart disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Heart rate recovery in response to disease targeted therapy in pre-capillary pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016


Exercise right heart catheterisation in the diagnosis of pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013


Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011



Hemodynamic assessment of patients with pulmonary hypertension due to lung disease and/or hypoxia
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013

Limited and heterogeneous arterial narrowing in idiopathic pulmonary hypertension: Rethinking resistance
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015